Business
Update to Faron's Financial Calendar for 2023
Update to Faron's Financial Calendar for 2023.
About this update from Faron Pharmaceuticals Oy
[{"type":"text","content":"\n \n \n Faron Pharmaceuticals Oy\n \n(\"Faron\" or \"Company\")\n \n \n Update to Faron's Financial Calendar for 2023\n \n \n \n \n \n \n Company announcement, February 6, 2023 at 1:00 PM (EST) / 6:00 PM (GMT) / 8:00 PM (EET)\n \n \n \n \n \n \n \n \n \n TURKU, FINLAND\n \n / BOSTON, MA - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on tackling difficult-to-treat cancers and inflammation via precision immunotherapy, today announces an update to its financial reporting calendar for 2023.\n \n \n \n \n \n The Company's financial statement release for the full year 2022 and Annual Report 2022, including financial statements for the full year, will now be published on Friday, March 3, 2023, at02:00 AM (EST) / 07:00 AM (GMT) / 09:00 AM (EET), rather than on Thursday, March 2, 2023, as had been previously communicated.\n \n The publication date of Tuesday, August 29, 2023, for Faron's half-year financial report for the period January 1 to June 30, 2023, remains unchanged, as does the date for the Company's annual general meeting, which is planned to be held on Friday, March 24, 2023. A separate stock exchange notice will be issued by Faron's board of directors to convene the meeting.\n \n \n Full Year Results Virtual Briefing\n \n \n Following publication of Faron's financial statement release for the full year 2022 on Friday, March 3, 2023, Dr. Markku Jalkanen, Chief Executive Officer, and Toni Hänninen, Chief Financial Officer, will host a virtual briefing and Q&A session for analysts on the day at 7:00 AM (EST) / 12:00 PM (GMT) / 2:00 PM (EET).\n \n The full year results press release for 2022, presentation, virtual briefing webcast details, and Annual Report 2022 will be made available at www.faron.com/investors. A replay of the analyst briefing will be made available shortly afterwards.\n \n For more details about the analyst briefing, please contact [email protected].\n \n \n \n \n \n \n \n \n \n \n \n For more information please contact:\n \n \n \n \n \n \n \n \n \n Investor Contact\n \n \n \n \n Faron Pharmaceuticals\n \n \n \n Julia Balanova\n \n \n VP, Investor Relations\n \n \n \n \n [email protected]\n \n \n \n \n \n \n [email protected]\n \n \n \n \n Phone: ...